Alkaissi H (2026). [PMID: 42113881](https://pubmed.ncbi.nlm.nih.gov/42113881/). *Endocr Relat Cancer*. [Basic Science / Preclinical]
LaRue M (2026). [PMID: 41419181](https://pubmed.ncbi.nlm.nih.gov/41419181/). *Endocr Pract*. [Clinical Trial Publication]
de Lapiscina IM (2026). [PMID: 41912295](https://pubmed.ncbi.nlm.nih.gov/41912295/). *Vitam Horm*. [Review / Meta-Analysis]
Duregon E (2026). [PMID: 41706251](https://pubmed.ncbi.nlm.nih.gov/41706251/). *Endocr Pathol*. [Basic Science / Preclinical]
Rodriguez M (2026). [PMID: 41632099](https://pubmed.ncbi.nlm.nih.gov/41632099/). *Cancer*. [Review / Meta-Analysis]
Park MJ (2026). [PMID: 41781348](https://pubmed.ncbi.nlm.nih.gov/41781348/). *J Intern Med*. [Epidemiology / Natural History]
Onkes M (2025). [PMID: 40445313](https://pubmed.ncbi.nlm.nih.gov/40445313/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Ruiz-Cánovas JM (2025). [PMID: 39343642](https://pubmed.ncbi.nlm.nih.gov/39343642/). *Hipertens Riesgo Vasc*. [Case Report / Case Series]
Li T (2025). [PMID: 39722564](https://pubmed.ncbi.nlm.nih.gov/39722564/). *Clin Endocrinol (Oxf)*. [Epidemiology / Natural History]
Berti V (2025). [PMID: 39666255](https://pubmed.ncbi.nlm.nih.gov/39666255/). *J Endocrinol Invest*. [Diagnostic / Biomarker]
